Please login to the form below
pipelines
This page shows the latest pipelines news and features for those working in and with pharma, biotech and healthcare.
Date set for EU antitrust regulators to decide on Pfizer’s $43bn Seagen acquisition
The proposed transaction would mark a significant boost to the US pharma’s oncology pipeline. ... The deal would also grant Pfizer access to Seagen’s drug development pipeline as well as its proprietary antibody-drug conjugate technology.
Latest news
-
Bristol Myers Squibb reveals plans to double number of drugs in registrational trials
The drugmaker expects to expand its research pipeline from six to 12 over next 18 months. ... The pipeline update includes a CD19-directed cell therapy expanding into clinical trials for immunologic diseases, a GPRC5D-targeting cell therapy starting a
-
Boehringer and Lilly’s Jardiance granted MHRA approval to treat chronic kidney disease
The approval comes less than two months after Lilly said it would be acquiring Versanis for over $1.9bn in a bid to expand its cardio-metabolic disease pipeline.
-
Novo Nordisk acquires Embark Biotech in deal worth over €470m
Novo Nordisk has announced its acquisition of Embark Biotech in a deal worth over 470m, marking another expansion of the Danish drugmaker’s cardiometabolic disease pipeline.
-
UK talent taskforce set up to tackle the decline in clinical trials
The report recommended the creation of US-style Centres of Excellence in Regulatory Science and Innovation (CERSIs) to provide a skills pipeline.
-
Regeneron to acquire Decibel Therapeutics in deal worth up to $213m
We believe that Decibel’s assets and specialised team will further strengthen our genetic medicines portfolio, enabling Regeneron to accelerate the development of innovative genetic therapies and a rich pipeline of ... Also commenting on the proposed
More from news
Approximately 14 fully matching, plus 2,072 partially matching documents found.
Latest Intelligence
-
The rise of biologics: is the sector ready for future demand?
Over the next few years, over 30 molecules will go off patent, many of which will be orphan drugs and have biosimilar competitors in the pipeline, thus further expanding the global ... Managing biologics and precision medicines like cell and gene therapy
-
Genomic medicine: collaborating for diverse data
There are also applications further down the pipeline. With the use of genome data and collaboration with different healthcare providers, we can identify genes that have risk factors that may lead
-
Driving conscious inclusion within organisations
Building a diverse leadership and talent pipeline. Organisations that practice fair and equitable treatment of their people, attract and retain top talent. ... More diversity in hiring requires more diversity in your applicant pool and there are steps
-
Tuberculosis – why it remains a major global public health challenge
What else is in the pipeline? We are working with several companies to develop a pipeline of novel TB therapeutic candidates.
-
Why diagnostics investments are crucial to win the AMR battle
We need more investments of the type being led by the AMR Action Fund to ensure there is a steady pipeline of new drugs available to treat evolving infections.
More from intelligence
Approximately 1 fully matching, plus 197 partially matching documents found.
Latest appointments
-
AZ appoints Susan Galbraith as executive vice president, oncology R&D
AZ. “She is also an exceptional leader who, together with her high-performing team, will continue to rapidly advance our exciting oncology pipeline and execute the strategy that Susan helped to
-
CureVac taps Klaus Edvardsen for chief development officer role
Looking ahead, his expertise will be of great value to us as we expand our pipeline, advance our technology platform and further grow our company.”.
-
Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm
I look forward to continuing to work with Dean over the next few months to advance our scientific strategy and continue the strong momentum in our pipeline,” he added.
-
New hires at Crescendo, Healx and Galecto
This experience will be crucial as we progress our pipeline of innovative, first in class, T cell enhancing programmes,” she added.
-
New hires at FibroGen, Saniona and Turbine
I am energised to join a company with such an innovative pipeline, as well as the first-in-class asset roxadustat, which has the potential to change the treatment paradigm in
More from appointments
Approximately 0 fully matching, plus 187 partially matching documents found.
Latest from PMHub
-
Rare and Orphan Diseases
1. It’s also predicted that by 2026 orphan drugs will make up almost 1/3 of the global drug pipeline’s value.
-
Can Artificial Intelligence Solve the Healthcare Crisis?
in the pipeline, and how safety and ethics are integral components for its success. ... There are 240 A.I tools in the pipeline for health and social care, but only 25% are mature enough to be used and only 20% have regulatory approval.
-
Why it’s time to apply a payer lens to your early pipeline planning
Value, evidence, and market access experts Jan McKendrick and Andrea Hamlin reveal why applying a payer lens early in the value assessment of pipeline assets is essential for driving commercial success.
-
The fast-paced future of cell and gene therapies
Read on to learn about:. An interview with Professor Francesco Dazzi, Medical Lead Cell Therapy, BioPharmaceuticals R&D at AstraZeneca, on the company’s novel cell therapy pipeline for chronic diseases.
-
Leveraging KOL insights to succeed in a data-driven world
KOLs have huge amounts of information about what’s really happening and, more than anything, have a pipeline into the perceptions of their colleagues that makes them an invaluable resource.”.
More from PMHub
Approximately 0 fully matching, plus 58 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
AMICULUM
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
